JUNE 9-11, 2025 | AUSTIN, TX |
Tissue engineering encompasses aspects of cells, materials, and biochemical, and physiochemical cues to restore, maintain, or replace tissue function. Disease modeling, whether it be in vitro or in vivo, aims to establish systems that resemble human diseases to improve our understanding of the mechanism of diseases or develop new therapies and diagnostic tools. Though these two areas are distinctly different in their end goals, there is significant conceptual and design overlap. Presentations in this session focus all aspects of tissue engineering or disease modeling including biomaterials, cells, growth factors, mechanical stimuli, and in vivo models and testing.
Please first review the information for authors — abstract submission guidelines.
Cryo(bio)printing to produce scaffolds for hard tissue engineering
Professor,UFPI - Universidade Federal do Piauí, Brazil
Advanced antimicrobial/virucidal composite coatings
Associate Professor,Politecnico di Torino, Italy
3D Bioprinting of Patient-Specific Regenerative Implants
Professor,Brazil University, Brazil
BioMechatronics - A Manifesto
Professor,European University of Applied sciences, Germany
Microfluidic Osteoarthritis-on-a-Chip: Evaluating Adverse Effects of Tanezumab in Co-Culture
Associate Professor,University of New England
Facing the Future: Tissue Engineered Treatment of Craniofacial Bone Injuries
Professor, Biomedical Engineering; Director, Translational Tissue Engineering Center,Johns Hopkins University
SPONSORS & PARTNERS
SBIR/STTR AGENCY PARTNERS
Subscribe to review event updates
Produced by
© Copyright 2025 TechConnect. All Rights Reserved. Disclaimer | Privacy Policy | Terms of Use